Investor Alert

New York Markets Open in:

Market Pulse Archives

April 28, 2021, 7:32 a.m. EDT

GlaxoSmithKline delivers profit beat, but sales disappoint

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    GlaxoSmithKline PLC ADR (GSK)
  • X
    GlaxoSmithKline PLC (GSK)

or Cancel Already have a watchlist? Log In

By Callum Keown

GlaxoSmithKline /zigman2/quotes/209463850/composite GSK +0.61% /zigman2/quotes/200381158/delayed UK:GSK -0.34% stock ticked higher on Wednesday after the British drugmaker beat profit expectations and said progress had been made on plans to split the company into two. GlaxoSmithKline reported turnover of £7.42 billion ($10.26 billion) in the first quarter, a 15% fall on the previous year at constant exchange rates, missing consensus estimates for £7.83 billion. Pre-tax profit fell 9% to £1.52 billion and operating profit declined 8% to £1.69 billion also lower than the Dow Jones consensus. However, adjusted earnings per share (EPS) of 22.9 pence beat the consensus for 21.9 pence. The company confirmed its full-year guidance for mid to high-single digit percentage adjusted EPS decline. Its 2022 outlook also remained unchanged, as the company saw meaningful improvements in revenues and margins. GlaxoSmithKline said it was "on track" to separate into two -- a new GSK and a standalone consumer healthcare company in 2022 -- and will reveal more details in June.

$ 41.37
+0.25 +0.61%
Volume: 3.91M
Dec. 1, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$101.04 billion
Rev. per Employee
UK : U.K.: London
1,536.00 p
-5.20 -0.34%
Volume: 890,766
Dec. 2, 2021 9:35a
P/E Ratio
Dividend Yield
Market Cap
£76.37 billion
Rev. per Employee

Get news alerts on GlaxoSmithKline PLC ADR — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.